InsiderClue
Insiders · Profile

Dylan-Hyde Tyler

Chief Legal Officer at CRISPR Therapeutics. Filing since 19 Apr 2017. CIK 0001682027

Company
Date
Role
Action
Shares
Amount
Of holding
CRSP CRISPR Therapeutics AG
16 Jan 2018
Chief Legal Officer
Sold, plan not stated
66,000
$1.85M
72.4%
CRSP CRISPR Therapeutics AG
2 Jan 2018
Chief Legal Officer
Sold, plan not stated
38,000
$822.50K
35.1%
CRSP CRISPR Therapeutics AG
29 Dec 2017
Chief Legal Officer
Sold, plan not stated
30,300
$689.06K
23.2%
CRSP CRISPR Therapeutics AG
28 Dec 2017
Chief Legal Officer
Sold, plan not stated
700
$15.23K
0.6%
CRSP CRISPR Therapeutics AG
22 Dec 2017
Chief Legal Officer
Sold, plan not stated
15,000
$308.25K
11.5%
CRSP CRISPR Therapeutics AG
15 Dec 2017
Chief Legal Officer
Sold, plan not stated
15,000
$283.50K
10.3%
CRSP CRISPR Therapeutics AG
8 Aug 2017
Chief Legal Officer
Sold, plan not stated
1,313
$24.42K
0.8%
CRSP CRISPR Therapeutics AG
7 Aug 2017
Chief Legal Officer
Sold, plan not stated
13,210
$245.21K
7.9%
CRSP CRISPR Therapeutics AG
4 Aug 2017
Chief Legal Officer
Sold, plan not stated
477
$8.85K
0.3%
CRSP CRISPR Therapeutics AG
1 May 2017
Chief Legal Officer
Sold, plan not stated
1,852
$30.75K
1.1%
CRSP CRISPR Therapeutics AG
28 Apr 2017
Chief Legal Officer
Sold, plan not stated
4,912
$81.64K
2.8%
CRSP CRISPR Therapeutics AG
27 Apr 2017
Chief Legal Officer
Sold, plan not stated
13,527
$227.80K
7.2%
CRSP CRISPR Therapeutics AG
26 Apr 2017
Chief Legal Officer
Sold, plan not stated
3,200
$53.64K
1.7%
CRSP CRISPR Therapeutics AG
25 Apr 2017
Chief Legal Officer
Sold, plan not stated
4,800
$80.99K
2.5%
CRSP CRISPR Therapeutics AG
24 Apr 2017
Chief Legal Officer
Sold, plan not stated
3,522
$57.90K
1.8%
CRSP CRISPR Therapeutics AG
21 Apr 2017
Chief Legal Officer
Sold, plan not stated
3,010
$51.22K
1.5%
CRSP CRISPR Therapeutics AG
20 Apr 2017
Chief Legal Officer
Sold, plan not stated
2,937
$51.03K
1.5%
CRSP CRISPR Therapeutics AG
19 Apr 2017
Chief Legal Officer
Sold, plan not stated
7,240
$129.17K
3.5%
18 decisions on file.